Search
Close
Search
Advanced Search
Search Menu
AI Discovery Assistant

Context:

Patients previously treated with desiccated thyroid extract (DTE), when being switched to levothyroxine (l-T4), occasionally did not feel as well despite adequate dosing based on serum TSH levels.

Objective:

Our objective was to investigate the effectiveness of DTE compared with l-T4 in hypothyroid patients.

Design and Setting:

We conducted a randomized, double-blind, crossover study at a tertiary care center.

Patients:

Patients (n = 70, age 18–65 years) diagnosed with primary hypothyroidism on a stable dose of l-T4 for 6 months were included in the study.

Intervention:

Patients were randomized to either DTE or l-T4 for 16 weeks and then crossed over for the same duration.

Outcome Measures:

Biochemical and neurocognitive tests at baseline and at the end of each treatment period were evaluated.

Results:

There were no differences in symptoms and neurocognitive measurements between the 2 therapies. Patients lost 3 lb on DTE treatment (172.9 ± 36.4 lb vs 175.7 ± 37.7 lb, P < .001). At the end of the study, 34 patients (48.6%) preferred DTE, 13 (18.6%) preferred l-T4, and 23 (32.9%) had no preference. In the subgroup analyses, those patients who preferred DTE lost 4 lb during the DTE treatment, and their subjective symptoms were significantly better while taking DTE as measured by the general health questionnaire-12 and thyroid symptom questionnaire (P < .001 for both). Five variables were predictors of preference for DTE.

Conclusion:

DTE therapy did not result in a significant improvement in quality of life; however, DTE caused modest weight loss and nearly half (48.6%) of the study patients expressed preference for DTE over l-T4. DTE therapy may be relevant for some hypothyroid patients.

Copyright © 2013 by The Endocrine Society
Issue Section:
Endocrine Care
You do not currently have access to this article.
Download all slides